Signifier receives significant investment
By HME News Staff
Updated 9:32 AM CDT, Thu March 24, 2022
BOSTON – Signifier Medical Technologies, a Boston-based medical technology company, has announced that Waha Capital PJSC, Angelus Sano Fund L.P., Segulah Medical Acceleration AB and certain other individual investors have collectively invested approximately $49 million in the purchase of existing shares in the company from shareholders unrelated to the board and management. Signifier's eXciteOSA medical device for the treatment of sleep disordered breathing has been launched in key markets, including the United States, Canada, the United Kingdom and Germany. “Signifier has made a tremendous amount of progress since receipt of FDA approval for eXcite,” said Hitesh Gupta, managing director, Waha Capital. “We are pleased with the successful commercial launch and are impressed by the positive patient outcomes and growth potential of this innovative technology. We are thrilled to be investing alongside domain experts in the medical technology space.” By using neuromuscular electrical stimulation (NMES) to “exercise” the upper airway muscles, eXciteOSA works the intrinsic and extrinsic tongue muscles to improve endurance and prevent airway collapse during sleep. Unlike other devices which are used while patients sleep, Signifier says eXciteOSA is the first commercially available device used while awake.
Comments